Aliasghar Children Hospital, Iran University of Medical Sciences, Tehran, Iran.
Pediatric Department, Kashan University of Medical Sciences, Kashan, Iran.
Pediatr Nephrol. 2021 Jul;36(7):1803-1808. doi: 10.1007/s00467-020-04904-w. Epub 2021 Jan 18.
Thromboembolism is one of the most important and dangerous complications of nephrotic syndrome. This study aimed to determine the value of albumin, anti-thrombin III, fibrinogen and D-dimer factors in the prediction of asymptomatic pulmonary embolism in patients with nephrotic syndrome in non-remission period.
Plasma levels of albumin, anti-thrombin III, fibrinogen and D-dimer were assessed in 30 nephrotic children in non-remission period (including new case-patient or relapse period), and the results were compared with chest X-ray and lung perfusion scintigraphy (Q scan).
The mean age of patients was 6.22 ± 3.5 years (range 2-12 years). Of patients, 23.3% had abnormal findings in perfusion scan suggestive of pulmonary emboli despite absence of any respiratory manifestations. Median plasma albumin and anti-thrombin III levels in patients with asymptomatic pulmonary embolism were lower than in patients without pulmonary embolism. Also, median fibrinogen and D-dimer levels in patients with asymptomatic pulmonary embolism were higher than in patients without pulmonary embolism, with no statistically significant differences between sex, age, hemoglobin and hematocrit of patients and lung perfusion scan results.
Patients with abnormal blood levels of albumin (< 3.5 g/dl), anti-thrombin III (< 80 ml/dl), fibrinogen (> 400 ml/dl) and D-dimer (> 0.5 μg/dl) underwent CXR/Q scan and were treated with heparin if there was pulmonary embolism.
血栓栓塞是肾病综合征最主要和最危险的并发症之一。本研究旨在探讨白蛋白、抗凝血酶 III、纤维蛋白原和 D-二聚体等因素在预测非缓解期肾病综合征患者无症状性肺栓塞中的价值。
检测 30 例非缓解期肾病儿童(包括新发病例或复发期)的血浆白蛋白、抗凝血酶 III、纤维蛋白原和 D-二聚体水平,并与胸部 X 线和肺灌注闪烁扫描(Q 扫描)结果进行比较。
患者的平均年龄为 6.22 ± 3.5 岁(年龄 2-12 岁)。尽管无任何呼吸道表现,但有 23.3%的患者灌注扫描异常,提示存在肺栓塞。无症状性肺栓塞患者的血浆白蛋白和抗凝血酶 III 中位数均低于无肺栓塞患者。此外,无症状性肺栓塞患者的纤维蛋白原和 D-二聚体中位数均高于无肺栓塞患者,但患者的性别、年龄、血红蛋白和血细胞比容以及肺灌注扫描结果之间无统计学差异。
如果存在肺栓塞,我们将对血液白蛋白水平异常(< 3.5 g/dl)、抗凝血酶 III 水平异常(< 80 ml/dl)、纤维蛋白原水平异常(> 400 ml/dl)和 D-二聚体水平异常(> 0.5 μg/dl)的患者进行 CXR/Q 扫描,并给予肝素治疗。